scispace - formally typeset
J

Jacob S. Appelbaum

Researcher at Yale University

Publications -  12
Citations -  1187

Jacob S. Appelbaum is an academic researcher from Yale University. The author has contributed to research in topics: Cell therapy & Chronic lymphocytic leukemia. The author has an hindex of 10, co-authored 12 publications receiving 1091 citations. Previous affiliations of Jacob S. Appelbaum include Fred Hutchinson Cancer Research Center & University of Washington.

Papers
More filters
Journal ArticleDOI

Suppression of IL7Ralpha transcription by IL-7 and other prosurvival cytokines: a novel mechanism for maximizing IL-7-dependent T cell survival.

TL;DR: A novel regulatory mechanism that specifically suppresses IL7Ralpha transcription in response to IL-7 and other prosurvival cytokines is described, suggesting that this homeostatic regulatory mechanism promotes survival of the maximum possible number of T cells for the amount ofIL-7 available.
Journal ArticleDOI

Selective recognition of protein tetraserine motifs with a cell-permeable, pro-fluorescent bis-boronic acid.

TL;DR: RhoBo functions as a cell-permeable, turn-on fluorescent sensor for tetraserine motifs in recombinant proteins and current efforts to identify optimal serine-rich sequences for RhoBo suggest it to function effectively as a selective small-molecule label for appropriately tagged proteins either upon or within living cells.
Journal ArticleDOI

Arginine Topology Controls Escape of Minimally Cationic Proteins from Early Endosomes to the Cytoplasm

TL;DR: These results suggest that the ability of 5.3 and ZF5.3 to escape from early endosomes is a unique feature and imply the existence of distinct signals, encodable within short sequences, that favor early versus late endosomal release.
Journal ArticleDOI

Bridged β3-Peptide Inhibitors of p53-hDM2 Complexation: Correlation between Affinity and Cell Permeability

TL;DR: The results highlight the relative merits of the cationic-patch and hydrophobic-bridge strategies for improving beta-peptide uptake and identify a surprising correlation between uptake efficiency and hDM2 affinity.
Journal ArticleDOI

Bipartite tetracysteine display reveals allosteric control of ligand-specific EGFR activation.

TL;DR: It is discovered that EGF binding is communicated to the cytosol through formation of an antiparallel coiled coil within the intracellular juxtamembrane (JM) domain, which suggests that the JM region can differentially decode extracellular signals and transmit them to the cell interior.